Nanotechnology has shown great promise in unraveling several important issues of
conventional anticancer chemotherapy. Expectations project that a new generation of …

The purpose of this paper is to summarize mode of action of cisplatin on the tumor cells, a
brief outlook on the metallocene compounds as antitumor drugs as well as the future …

The book examines the design, application, and utilization of devices, techniques, and
technologies critical to research at the atomic, molecular, and macromolecular levels …

The aim of this mini review was to report the molybdenum compound intervention to control
cancer disease. The intervention explains its roles and progress from inorganic …

Seven hexacoordinated cis-dioxidomolybdenum (VI) complexes [MoO 2 L 1–7](1‐7) derived
from various tetradentate diamino bis (phenolato)“salan” ligands, N, N′-dimethyl-N, N′-bis …

A series of alkenyl‐substituted titanocene compounds have been supported on the
mesoporous silica‐based material KIT‐6. The corresponding functionalised materials were …

This work describes cytotoxic effect of non-platinum metal-based compounds on the human
T-leukemic cells with different p53 status (p53 wild-type MOLT-4 and p53-deficient Jurkat …

Investigations on the antitumor activity of metallacarboranes are sparse in the literature and
limited to a handful of ruthena‐and molybdacarboranes. In this study, the molybdacarborane …

The CO releasing ability of the complex [CpMo (CO) 3Me](1)(Cp= η5-C5H5) has been
assessed using a deoxymyoglobin-carbonmonoxymyoglobin assay. In the dark, CO release …

A series of allyl molybdenum [(η3-C3H5) Mo (CO) 2L2Cl],[(η3-C3H4COOMe) Mo (CO)
2L2Br], cyclopentadienyl molybdenum [(η5-C5H4R) Mo (CO) 2L2][BF4](R= H, 4 …